trial

COllaborative Shared Care to IMprove Psychosis Outcome

NCTId NCT02895269
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 307 (actual)
Sponsored by University of Ibadan
Primary completion 2017-10
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
307 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2016-09
Primary completion
2017-10
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Collaborative shared care

Sponsors

University of IbadanLead Sponsor

Investigators

1
Oye Gureje, DScPrincipal Investigator

Sites

2 total
Kumasi, GhanaIbadan, Nigeria

Facts & assertions

4 sourced
Enrollment
307
Phase
NA
Primary Completion Date
2017-10
Status
COMPLETED
relationships
The graph out of here
drug
Collaborative shared care
drug
lead_sponsor
University of Ibadan
company
indication
Psychosis
indication
Psychotic Disorders
indication
investigator
Oye Gureje, DSc
person